In people with HIV taking antiretroviral therapy, excessive visceral abdominal fat drives cardiovascular disease risk, even ...

Change does not happen overnight. Democracy does not suddenly collapse. It is a series of restrictive policies and an ...

Procore Technologies, Inc. , the leading global provider of construction management software, today announced that it will report its first quarter fiscal year 2025 financial results after the U.S.

Gilead Sciences Inc. closed 15.47% short of its 52-week high of $119.96, which the company reached on March 10th.

Well, for years, I wrote short essays to kick off our monthly Motley Fool issues. I'm a quoting, as I say that they used to ...

Prezent, the enterprise-grade AI platform for business presentations, today announced the strategic appointment of Janet ...

The number of employees laid off dropped year over year during the first quarter. BioSpace recaps the five largest layoffs, ...

NORTHAMPTON, MA / ACCESS Newswire / April 10, 2025 / At Gilead, putting people first is central to all we do. That's why we're proud to be recognized as a responsible company by patient advocacy group ...

A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences ...

Initiated Phase 1/2 study expansion for IDE397, IDEAYA's MAT2A inhibitor, in combination with Trodelvy®, Gilead's Trop-2 directed ADC, in MTAP-deletion urothelial ...

NORTHAMPTON, MA / ACCESS Newswire / April 10, 2025 / At Gilead, putting people first is central to all we do. That's why ...

IDEAYA Biosciences, Inc. (Nasdaq:IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced the initiation of a Phase 1/2 expansion in ...